pioglitazone hydrochloride

Generic: pioglitazone hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pioglitazone hydrochloride
Generic Name pioglitazone hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pioglitazone hydrochloride 30 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6393
Product ID 50090-6393_7bd7e748-e0f3-491e-845c-e1ad44613642
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200268
Listing Expiration 2027-12-31
Marketing Start 2013-02-13

Pharmacologic Class

Classes
peroxisome proliferator receptor alpha agonist [epc] peroxisome proliferator receptor gamma agonist [epc] peroxisome proliferator-activated receptor alpha agonists [moa] peroxisome proliferator-activated receptor gamma agonists [moa] thiazolidinedione [epc] thiazolidinediones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906393
Hyphenated Format 50090-6393

Supplemental Identifiers

RxCUI
312440
UNII
JQT35NPK6C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pioglitazone hydrochloride (source: ndc)
Generic Name pioglitazone hydrochloride (source: ndc)
Application Number ANDA200268 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-6393-0)
  • 90 TABLET in 1 BOTTLE (50090-6393-1)
source: ndc

Packages (2)

50090-6393-0 30 TABLET in 1 BOTTLE (50090-6393-0) 50090-6393-1 90 TABLET in 1 BOTTLE (50090-6393-1)

Ingredients (1)

pioglitazone hydrochloride (30 mg/1)

Linked Drug Pages (1)

PIOGLITAZONE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7bd7e748-e0f3-491e-845c-e1ad44613642", "openfda": {"unii": ["JQT35NPK6C"], "rxcui": ["312440"], "spl_set_id": ["29073b0a-1d7e-4354-87c7-e764106978d8"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-6393-0)", "package_ndc": "50090-6393-0", "marketing_start_date": "20230310"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6393-1)", "package_ndc": "50090-6393-1", "marketing_start_date": "20230310"}], "brand_name": "PIOGLITAZONE HYDROCHLORIDE", "product_id": "50090-6393_7bd7e748-e0f3-491e-845c-e1ad44613642", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "50090-6393", "generic_name": "pioglitazone hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PIOGLITAZONE HYDROCHLORIDE", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA200268", "marketing_category": "ANDA", "marketing_start_date": "20130213", "listing_expiration_date": "20271231"}